
The University of Texas MD Anderson Cancer Center has commenced construction on a new 470,000ft² facility in Sugar Land, aiming to enhance cancer care services in Southwest Houston, US.
Scheduled to open in 2029, the five-storey building will become MD Anderson’s most extensive location in the Houston area.
The MD Anderson Cancer Center expansion will offer a range of services, including a new ambulatory surgery centre and increased capabilities in diagnostic imaging, radiation oncology, and outpatient procedures.
The new facility will not only expand the services of MD Anderson’s existing Sugar Land location but will also house multidisciplinary clinics to provide care for adult cancer patients with varying needs.
MD Anderson president Peter WT Pisters said: “By expanding our reach in Sugar Land, we can better meet the needs of patients in Southwest Houston, making it easier for them to access the treatment and support they deserve, right in their own community.”
MD Anderson currently operates six facilities beyond its main campus at the Texas Medical Center.
The new Sugar Land location will take over from the current leased space at 1327 Lake Pointe Parkway and is designed with the capacity for future expansion to accommodate growing patient demand.
MD Anderson senior vice-president and chief operating officer Rosanna Morris said: “This facility comes at a pivotal moment as we strive to continue meeting the needs of our patients across Houston.
“This not only will help make our care more convenient for local patients, especially those undergoing frequent treatments like chemotherapy or radiation, but it also will help increase access to care outside of our Texas Medical Center Campus, potentially decreasing wait times for both local and regional patients.”
In line with MD Anderson’s sustainability objectives, the design of the new facility aims to lessen energy consumption, optimise natural light usage, and minimise glare and heat gain.
In August 2023, the Cancer Prevention and Research Institute of Texas awarded approximately $4.9m to the University of Texas MD Anderson Cancer Center to support its cancer prevention programmes and faculty recruitment efforts.